According to 89bio's latest financial reports the company has a price-to-book ratio of 1.65.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2023-12-31 | 1.94 | -50.25% |
2022-12-31 | 3.90 | 85.39% |
2021-12-31 | 2.10 | -11.83% |
2020-12-31 | 2.39 | -40.78% |
2019-12-31 | 4.03 | |
2018-12-31 | N/A |
Company | P/B ratio | differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | 2.71 | 64.93% | ๐บ๐ธ USA |